Atgc Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 4.95 M
- Paid Up Capital ₹ 4.50 M
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
- Revenue Growth -63.30%
- Profit Growth 35.23%
- Ebitda 26.42%
- Net Worth -174.30%
- Total Assets -25.57%
About Atgc Diagnostics
Atgc Diagnostics Private Limited (ADPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 03 December 2015 (Nine years and two months 0 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.95 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹3.00 M.
Syed Kabir, Siddhartha Roy, Ashok Giri, and Two other members serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85100WB2015PTC208619
- Company No.
208619
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Atgc Diagnostics?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Susanta Roychoudhury  | Director | 03-Dec-2015 | Current |
| Siddhartha Roy | Director | 03-Dec-2015 | Current |
| Ashok Giri | Director | 03-Dec-2015 | Current |
| Syed Kabir | Director | 03-Dec-2015 | Current |
| Kunal Ray | Additional Director | 20-Jun-2018 | Current |
Financial Performance of Atgc Diagnostics.
Atgc Diagnostics Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 63.3% decrease. The company also saw a substantial improvement in profitability, with a 35.23% increase in profit. The company's net worth observed a substantial decline by a decrease of 174.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atgc Diagnostics?
In 2019, Atgc Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Repro-Med Diagnostic Pvt. Ltd.Syed Kabir is a mutual person
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2016 | State Bank Of India | ₹3.00 M | Open |
How Many Employees Work at Atgc Diagnostics?
Unlock and access historical data on people associated with Atgc Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atgc Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atgc Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
